Watch Ticker

Ikena Oncology, Inc. Common Stock

Go to Ikena Oncology, Inc. Common Stock Website

$17.16

(%)
Live
Previous Close

$17.16

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

Nasdaq

...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

Inmagene Biopharmaceuticals completed a merger with Ikena Oncology, creating ImageneBio, Inc., and raised $75 million in a private placement. The combined company will continue developing IMG-007, a non-depleting anti-OX40 monoclonal antibody for atopic dermatitis, with a Phase 2b trial expected to have topline results in Q4 2026.

Related tickers: IKNA.

Read Full Article

Inmagene Biopharmaceuticals completed a merger with Ikena Oncology, creating ImageneBio, Inc., and raised $75 million in a private placement. The combined company will continue developing IMG-007, a non-depleting anti-OX40 monoclonal antibody for atopic dermatitis.

Related tickers: IKNA.

Read Full Article
Trending Tickers

Please sign in to view